It is with mixed emotions that we share an update from OcuTerra. Our journey has been one of passion, dedication and hope in combating diabetic retinopathy, a sight-threatening disease affecting millions globally. Three years ago, we embarked on a groundbreaking mission to pioneer a non-invasive treatment for diabetic retinopathy, a game-changer named nesvategrast delivered via simple eye drops. Our vision was clear: to provide early intervention and potentially prevent the progression of this debilitating condition that can cause blindness. Recently, we concluded the DR:EAM phase 2 clinical trial with nesvategrast. Despite our unwavering commitment and the tireless efforts of our team, the trial did not yield the anticipated results. We've since delved deep into analyses, seeking to grasp the full picture and consider potential ways forward. In alignment with our values and commitment to scientific integrity, OcuTerra has made the difficult decision to wind down operations. This decision ensures transparency and accountability to our investors and stakeholders. We extend our heartfelt gratitude to our remarkable team for their exceptional work in designing and executing the DR:EAM trial. We also express sincere appreciation to the clinicians, patients, board of directors, scientific advisors, investors and supporters who believed in our mission. Though our journey with OcuTerra may conclude, our commitment to advancing important new therapies for ophthalmic disease remains steadfast. Thank you for being part of our journey.
Well done in trying to make a unique difference in patients lives!
Unfortunately, it takes more than an all-star team that you are to get a drug to market. While I'm saddened by the end of your run, I have high hopes for all of your future endeavors. Keep at it, and keep swinging for the fences. 💪
Susannah Sinozich Kerrie Brady Majid Anderesi, MD David J. Tanzer, MD and the rest of the OcuTerra Therapeutics team, thank you for all of your hard work in the fight against diabetic eye diseases. I am sure there was data and lessons learned that can be used for another approval, so this was not a failure. Your dedication and commitment was inspiring. I can't wait to see what you will all do next. Chin up and truly, Thank you.
It’s mostly the difficult decisions we make that define us, that make us who we are. As much as this decision was difficult, I am sure everyone has grown and learned and in addition, this data will help us all better understand DR and will help develop new therapies that will enable our patients live better lives. The quest for better therapies for our patients it’s difficult and full of what at the time seems as unsurpassable challenges but they all add to our growth. A big hug and best wishes
There are such eloquent and well said comments to this post. I can only add that it's been an honour and pleasure indeed to know the OcuTerra team of great people, as well as being an admirer of the technology and molecule and the great potential to have displaced intraocular injections (that I, along with many, fear greatly). Congratulations on the heroic efforts and looking forward to your next endeavours.
Best wishes to the Ocuterra team. Your passion was well-noticed and I’m sure we’ll see each of you again in the very near future. All my best!
Kerrie, I am sad for you and your team that this journey has come to an end. But, I am so proud of you and your leadership. You were meant to be a CEO almost from the time I met you. You were prepared and you planned for the possibility that this “experiment” might fail - as so many experiments in our industry do. I know that you will have a new leadership role soon - you just need to decide which team you want to lead. Brava to the whole OcuTerra team.
What a team the OcuTerra Therapeutics team are. You may not have got the results you had hoped for this time but I have no doubt you will continue contributing and making a difference to the patients we serve. Excited to see what you all work on next. Wishing you all onward success in your next chapters.
While this is bittersweet, I’m excited for the ground you broke and the impact you had on the industry. Wishing you the best!
Clinical Applications Manager, COMT
3moIt is never a failure when you work toward a goal, sometimes you don't get to the finish you expected or wanted. Knowing that you put time, effort, sweat and tears into finding solutions for patients is the most important thing.One of the best lessons I have learned in life is to not let failure label you. The work we put into something for the greater good will always be important. Here is what you can take away from this, you tried to find solutions, you worked to help people. Learn from it and go on, how important is it to know what doesn't work, so we can find what does!